• HOME
  • RESEARCH
  • PEOPLE
    • Matthew S. Davids
    • Current Lab Members >
      • Christine Ryan, MD
      • Stephen Chong, PhD
      • Fen Zhu, PhD
      • Johannes Hildebrand, MSc
      • Mary Collins, BS
      • Liam Hackett, AB
    • Alumni >
      • Charles Herbaux, MD
      • Rebecca Valentin, MD
      • Timothy Lehmberg, B.A.
      • Stephanie Grabow, PhD
      • Simon Husby, MD
  • PUBLICATIONS
  • JOBS
  • SUPPORT US
  • NEWS
    • Awards and Recognition
  • CONTACT
Davids Lab - Translational CLL Research

The Davids Lab
TRANSLATIONAL CLL RESEARCH

Picture

Welcome to the Davids Lab!

The last few years have witnessed a transformation in the approach to treating patients with chronic lymphocytic leukemia (CLL), yet for most patients the disease remains incurable.  We are a translational research laboratory that studies patient samples from our clinical trials utilizing novel agents that are in development or recently approved.  We focus on interrogating the mitochondrial pathway of apoptosis through BH3 profiling to predict response and resistance to these treatments, with a goal to eventually use this technique to guide therapeutic decisions.

Picture
Picture
Picture
Picture
 HOME | RESEARCH | PEOPLE | PUBLICATIONS | JOBS | SUPPORT US | NEWS | CONTACT 

©2016 Translational CLL Research at Dana-Farber Cancer Institute